Form 4/A for RGS REGIS CORP
Accepted 2021-11-16 00:00:00 ET · period of report 2021-11-05 · accession 0001179110-21-010175 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2021-11-16 | 2021-11-05 | RGS | Doctor Matthew | EVP, Chief Strategy Off | A - Grant | $0.00 | +46.3K | 87.7K | +112% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-05 | A | A | 46,344 | $0.00 | 87,710 | D | — | — | (F1) The Reporting Person was awarded a grant of 46,344 restricted stock units (RSUs) pursuant to the SPMP. The RSUs will vest 20% on the first anniversary of the grant date, 20% on the second anniversary of the grant date, and 60% on the third anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer through such anniversaries and the other terms and conditions of the grant agreement. Each RSU represents the contingent right to receive one share of RGS common stock upon vesting. |